title: Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Prasanth
authors.initials: P
authors.lastname: Ganesan
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Siraj M
authors.initials: SM
authors.lastname: Ali
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Kai
authors.initials: K
authors.lastname: Wang
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: George R
authors.initials: GR
authors.lastname: Blumenschein
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Bita
authors.initials: B
authors.lastname: Esmaeli
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Wolff
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Vincent A
authors.initials: VA
authors.lastname: Miller
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Phillip J
authors.initials: PJ
authors.lastname: Stephens
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Jeffery S
authors.initials: JS
authors.lastname: Ross
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Gary A
authors.initials: GA
authors.lastname: Palmer
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX fjanku@mdanderson.org.
authors.forename: Filip
authors.initials: F
authors.lastname: Janku
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D000068818:Cetuximab / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; C512478:EGFR protein, human; D066246:ErbB Receptors; D000068818:Cetuximab